The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons
Abstract
Glial cell‐lined derived neurotrophic factor (GDNF) has been shown to promote survival of developing mesencephalic dopaminergic neurons in vitro. In order to determine if there is a positive effect of GDNF on injured adult midbrain dopaminergic neurons in situ, we have carried out experiments in which a single dose of GDNF was injected into the substantia nigra following a unilateral lesion of the nigrostriatal system. Rats were unilaterally lesioned by a single stereotaxic injection of 6‐hydroxydopamine (6‐OHDA; 9 μg/4 μl normal saline with 0.02% ascorbate) into the medial forebrain bundle and tested weekly for apomorphine‐induced (0.05 mg/kg s. c. ) contralateral rotation behavior, Rats that manifested >300 turns/hour received a nigral injection of 100 μg GDNF, or cytochrome C as a control, 4 weeks following the 6‐OHDA lesion, Rotation behavior was quantified weekly for 5 weeks after GDNF. Rats were subsequently anesthetized, transcardially perfused, and processed for tyrosine hydroxylase immunohistochemistry. It was found that 100 μg GDNF decreased apomorphine‐induced rotational behavior by more than 85%. Immunohistochemical studies revealed that tyrosine hydroxylase immunoreactivity was equally reduced in the striatum ipsilateral to the lesion in both cytochrome C and GDNF‐injected animals. In contrast, large increments in tyrosine hydroxylase immunoreactivity were observed in the substantia nigra of animals treated with 100 μg of GDNF, with a significant increase in numbers of tyrosine hydroxylase‐immunoreactive cell bodies and neurites as well as a small increase in the cell body area of these neurons. The results suggest that GDNF can maintain the dopaminergic neuronal phenotype in a number of nigral neurons following a unilateral nigrostriatal lesion in the rat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,205
Ungerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,978
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11000.x · Cited by 1,922
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11001.x · Cited by 1,290
Nerve Growth Factor Treatment After Brain Injury Prevents Neuronal Death
Kromer, L. F. (1987) · Science · doi:10.1126/science.3798108 · Cited by 932
Evidence for dopamine receptor stimulation by apomorphine
Andén, N.-E., Rubenson, A., Fuxe, K., & Hökfelt, T. (1967) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1967.tb09604.x · Cited by 908
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants
Bjo¨rklund, A., & Stenevi, U. (1979) · Brain Research · doi:10.1016/0006-8993(79)90472-4 · Cited by 830
Dendritic release of dopamine in the substantia nigra
Cheramy, A., Leviel, V., & Glowinski, J. (1981) · Nature · doi:10.1038/289537a0 · Cited by 735
Release of dopamine from dendrites in rat substantia nigra
GEFFEN, L. B., JESSELL, T. M., CUELLO, A. C., & IVERSEN, L. L. (1976) · Nature · doi:10.1038/260258a0 · Cited by 650
Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., & Hefti, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.961 · Cited by 603
Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine
BREESE, G. R., & TRAYLOR, T. D. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb07089.x · Cited by 527
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals
Bjo¨rklund, A., & Lindvall, O. (1975) · Brain Research · doi:10.1016/0006-8993(75)90849-5 · Cited by 483
Hoffer, B. J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453
Self-citationFunctional Role of the Nigro‐Neostriatal Dopamine Neurons*)
Andén, N., Dahlström, A., Fuxe, K., & Larsson, K. (1966) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1966.tb00389.x · Cited by 390
Strömberg, I., Björklund, L., Johansson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B., & Humpel, C. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1214 · Cited by 380
Self-citationA Quantitative Study on the Nigro‐Neostriatal Dopamine Neuron System in the Rat
Andén, N., Fuxe, K., Hamberoer, B., & Hökfelt, T. (1966) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1966.tb03317.x · Cited by 379
Hudson, J. L., van Horne, C. G., Strömberg, I., Brock, S., Clayton, J., Masserano, J., Hoffer, B. J., & Gerhardt, G. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90576-9 · Cited by 377
Self-citationRegional and Cell-Specific Expression of GDNF in Rat Brain
Scharr, D. G., Sieber, B.-A., Dreyfus, C. F., & Black, I. B. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1207 · Cited by 272
Applications of Multivariate Analysis of Variance to Repeated Measurements Experiments
Cole, J. W. L., & Grizzle, J. E. (1966) · Biometrics · doi:10.2307/2528076 · Cited by 269
Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo
Hudson, J., Granholm, A.-C., Gerhardt, G. A., Henry, M. A., Hoffman, A., Biddle, P., Leela, N. S., Mackerlova, L., Lile, J. D., Collins, F., et al. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00224-o · Cited by 242
Self-citationMarshall, J. F., & Ungerstedt, U. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90256-4 · Cited by 202
Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms
Robertson, G., & Robertson, H. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-09-03326.1989 · Cited by 198
Hedreen, J. C., & Chalmers, J. P. (1972) · Brain Research · doi:10.1016/0006-8993(72)90248-x · Cited by 182
Hemisyndromes, psychobiology, neurology, psychiatry
Myslobodsky, M. S. (1983) · Academic Press eBooks · Cited by 148
Date, I., Notter, M. F. D., Felten, S. Y., & Felten, D. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)90264-c · Cited by 145
Robertson, G. S., Damsma, G., & Fibiger, H. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-07-02209.1991 · Cited by 139
Blanchard, V., Raisman‐Vozari, R., Vyas, S., Michel, P. P., Javoy-Agid, F., Uhl, G. R., & Agid, Y. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90029-9 · Cited by 129
Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro
Tomozawa, Y., & Appel, S. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)90605-0 · Cited by 124
Striatal Efferent Fibers Play a Role in Maintaining Rotational Behavior in the Rat
Marshall, J. F., & Ungerstedt, U. (1977) · Science · doi:10.1126/science.897683 · Cited by 123
Robertson, G. S., Herrera, D. G., Dragunow, M., & Robertson, H. A. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90049-6 · Cited by 120
Kordower, J. H., Charles, V., Bayer, R. A., Bartus, R. T., Putney, S. D., Walus, L. R., & Friden, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9077 · Cited by 116
Bracha, H. S., Shults, C. W., Glick, S. D., & Kleinman, J. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90576-5 · Cited by 106
Mufson, E. J., Kroin, J. S., Sobreviela, T., Burke, M. A., Kordower, J. H., Penn, R. D., & Miller, J. A. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1143 · Cited by 102
Conner, J. M., & Varon, S. S. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903260304 · Cited by 76
Intrastriatal implantation of interleukin-1
Wang, J., Bankiewicz, K. S., Plunkett, R. J., & Oldfield, E. H. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0484 · Cited by 69
Evidence that the substantia nigra is a site of action for l-DOPA
Robertson, G. S., & Robertson, H. A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90382-5 · Cited by 65
Carvey, P. M., Ptak, L. R., Nath, S. T., et al. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1049 · Cited by 48
Nissbrandt, H., Pileblad, E., & Carlsson, A. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb04994.x · Cited by 45
Recovery of function after mesotelencephalic dopaminergic injury in senescence
Marshall, J. F., Drew, M. C., & Neve, K. A. (1983) · Brain Research · doi:10.1016/0006-8993(83)91255-6 · Cited by 39
Beck, T., Wree, A., & Sauer, D. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90448-g · Cited by 27
Organotypic slice cultures of dopaminergic neurons of substantia nigra
Jaeger, C. B., Ruiz, A. G., & Llinás, R. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90010-5 · Cited by 25
Should Intracerebroventricular Nerve Growth Factor Be Used to Treat Alzheimer's Disease?
Saffran, B. N. (1992) · Perspectives in biology and medicine · doi:10.1353/pbm.1992.0055 · Cited by 20
Lesion-induced catecholaminergic sprouting in the interpeduncular nucleus
Gottesfeld, Z. (1984) · Neurochemical Research · doi:10.1007/bf00963981 · Cited by 16
Effects of levodopa and dopamine on plasma glucose concentration in mice
Darwish, S. A. E., & Furman, B. L. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90255-2 · Cited by 12
Behavioral Correlates of Plasticity in Substantia Nigra Efferents
Huston, J. P., Morgan, S., & Steiner, H. (1985) · Advances in behavioral biology · doi:10.1007/978-1-4684-5003-3_39 · Cited by 8
Cited by
Functional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
Self-citationSCHWARTING, R., & HUSTON, J. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 737
Neurturin, a relative of glial-cell-line-derived neurotrophic factor
Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., Johnson Jr, E. M., & Milbrandt, J. (1996) · Nature · doi:10.1038/384467a0 · Cited by 710
Bennett, D. L. H., Michael, G. J., Ramachandran, N., Munson, J. B., Averill, S., Yan, Q., McMahon, S. B., & Priestley, J. V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-03059.1998 · Cited by 627
Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
Choi-Lundberg, D. L., Lin, Q., Chang, Y.-N., Chiang, Y. L., Hay, C. M., Mohajeri, H., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 625
Metadata
- Authors
- Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P. T., Hoffer, B. J., & Granholm, A. E.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1995-05-15
- Volume
- 355
- Issue
- 4
- Pages
- 479-489
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2050784054
- Cited by
- 290
- References
- 47
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.